Long Non-coding RNA MIR17HG Sponges MicroRNA-21 to Upregulate PTEN and Regulate Homoharringtonine-based Chemoresistance of Acute Myeloid Leukemia Cells

Overview

Journal Oncol Lett

Specialty Oncology

Date 2021 Dec 6

PMID 34868361

Citations 9

Authors

Jinhua Yan

Ling Yao

Ping Li

Guohe Wu

Xiaobin Lv

Affiliations

Soon will be listed here.

Abstract

Long non-coding (lnc)RNA MIR17HG has been identified as a oncogene whose roles in acute myeloid leukemia (AML) remain unclear. The present study aimed to investigate the role of lncRNA MIR17HG in AML. Differential expression of MIR17HG in AML was determined by reverse transcription-quantitative PCR. Overexpression assays and dual luciferase reporter assays were performed to determine the relationship between MIR17HG and microRNA (miR)-21, and apoptosis was analyzed by using an apoptosis assay. The results showed that the expression of MIR17HG was decreased in AML, which was further decreased following homoharringtonine (HHT)-based chemotherapy. Bioinformatics analysis predicted that miR-21 could bind with MIR17HG. However, miR-21 overexpression had no effect on the expression level of MIR17HG. Dual luciferase reporter assays were performed to verify the direct interaction between miR-21 and MIR17HG. In addition, overexpression of MIR17HG and miR-21 in AML cell lines up- and downregulated the expression level of PTEN, respectively. Furthermore, cell apoptosis showed that MIR17HG and PTEN overexpression enhanced cell apoptosis following cell treatment with HTT. However, miR-21 overexpression exerted the opposite effect, since it reversed the effects of MIR17HG and PTEN overexpression in AML cell apoptosis. In conclusion, the current study suggested that MIR17HG could regulate the miR-21/PTEN axis to modulate the chemoresistance of AML cells.

Citing Articles

Homoharringtonine in the treatment of acute myeloid leukemia: A review.

Shen S, Zhuang H Medicine (Baltimore). 2024; 103(44):e40380.

PMID: 39496012 PMC: 11537654. DOI: 10.1097/MD.0000000000040380.

Role of MicroRNA-21 in Prostate Cancer Progression and Metastasis: Molecular Mechanisms to Therapeutic Targets.

Singh V, Rajak N, Singh Y, Singh A, Giri R, Garg N Ann Surg Oncol. 2024; 31(7):4795-4808.

PMID: 38758485 DOI: 10.1245/s10434-024-15453-z.

A 69 long noncoding RNA signature predicts relapse and acts as independent prognostic factor in pediatric AML.

Ren Z, Vanhooren J, Derpoorter C, De Moerloose B, Lammens T Blood Adv. 2024; 8(12):3299-3310.

PMID: 38640434 PMC: 11226973. DOI: 10.1182/bloodadvances.2024012667.

A Circular RNA Generated from Nebulin (NEB) Gene Splicing Promotes Skeletal Muscle Myogenesis in Cattle as Detected by a Multi-Omics Approach.

Huang K, Li Z, Zhong D, Yang Y, Yan X, Feng T Adv Sci (Weinh). 2023; 11(3):e2300702.

PMID: 38036415 PMC: 10797441. DOI: 10.1002/advs.202300702.

Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways.

Rahmati A, Mafi A, Vakili O, Soleymani F, Alishahi Z, Yahyazadeh S Ann Hematol. 2023; 103(5):1455-1482.

PMID: 37526673 DOI: 10.1007/s00277-023-05383-3.

References

Liu H, Zhu C, Xu Z, Wang J, Qian L, Zhou Q . lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma. Cancer Sci. 2020; 111(11):4129-4141. PMC: 7648017. DOI: 10.1111/cas.14649. View

Wei S, Liu J, Li X, Liu X . LncRNA MIR17HG inhibits non-small cell lung cancer by upregulating miR-142-3p to downregulate Bach-1. BMC Pulm Med. 2020; 20(1):78. PMC: 7104535. DOI: 10.1186/s12890-020-1112-3. View

Zhao H, Shi P, Deng M, Jiang Z, Li Y, Kannappan V . Low dose triptolide reverses chemoresistance in adult acute lymphoblastic leukemia cells via reactive oxygen species generation and DNA damage response disruption. Oncotarget. 2016; 7(51):85515-85528. PMC: 5356754. DOI: 10.18632/oncotarget.13454. View

Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y . miR-21-mediated tumor growth. Oncogene. 2006; 26(19):2799-803. DOI: 10.1038/sj.onc.1210083. View

Tan M, Zhang Q, Yuan X, Chen Y, Wu Y . Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms. J Exp Clin Cancer Res. 2019; 38(1):308. PMC: 6631946. DOI: 10.1186/s13046-019-1295-8. View

Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal J . The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 2008; 8(3):187-98. DOI: 10.2174/156800908784293659. View

Feng J, Ouyang Y, Xu D, He Q, Liu D, Fan X . Genetic variants in MIR17HG affect the susceptibility and prognosis of glioma in a Chinese Han population. BMC Cancer. 2020; 20(1):976. PMC: 7547478. DOI: 10.1186/s12885-020-07417-9. View

Liu Z, Wang H, Liu J, Wang Z . MicroRNA-21 (miR-21) expression promotes growth, metastasis, and chemo- or radioresistance in non-small cell lung cancer cells by targeting PTEN. Mol Cell Biochem. 2012; 372(1-2):35-45. DOI: 10.1007/s11010-012-1443-3. View

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

10.

Militello G, Weirick T, John D, Doring C, Dimmeler S, Uchida S . Screening and validation of lncRNAs and circRNAs as miRNA sponges. Brief Bioinform. 2016; 18(5):780-788. DOI: 10.1093/bib/bbw053. View

11.

Kuroda J, Kamitsuji Y, Kimura S, Ashihara E, Kawata E, Nakagawa Y . Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin. Int J Hematol. 2008; 87(5):507-515. DOI: 10.1007/s12185-008-0081-8. View

12.

Xu X, Qian J, Deng Z, Cai Z, Tang T, Wang P . Expression of miR-21, miR-31, miR-96 and miR-135b is correlated with the clinical parameters of colorectal cancer. Oncol Lett. 2012; 4(2):339-345. PMC: 3402725. DOI: 10.3892/ol.2012.714. View

13.

Pink R, Samuel P, Massa D, Caley D, Brooks S, Carter D . The passenger strand, miR-21-3p, plays a role in mediating cisplatin resistance in ovarian cancer cells. Gynecol Oncol. 2015; 137(1):143-51. DOI: 10.1016/j.ygyno.2014.12.042. View

14.

Yang S, Huang C, Li X, Yu M, He Y, Li J . miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology. 2013; 306:162-8. DOI: 10.1016/j.tox.2013.02.014. View

15.

Zheng H . The molecular mechanisms of chemoresistance in cancers. Oncotarget. 2017; 8(35):59950-59964. PMC: 5601792. DOI: 10.18632/oncotarget.19048. View

16.

Khwaja A, Bjorkholm M, Gale R, Levine R, Jordan C, Ehninger G . Acute myeloid leukaemia. Nat Rev Dis Primers. 2016; 2:16010. DOI: 10.1038/nrdp.2016.10. View

17.

Zhang J, Yao T, Wang Y, Yu J, Liu Y, Lin Z . Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21. Cancer Biol Ther. 2015; 17(1):104-13. PMC: 4847830. DOI: 10.1080/15384047.2015.1108496. View

18.

Estey E, Dohner H . Acute myeloid leukaemia. Lancet. 2006; 368(9550):1894-907. DOI: 10.1016/S0140-6736(06)69780-8. View

19.

Shi X, Zhu M, Gong Z, Yang T, Yu R, Wang J . Homoharringtonine suppresses LoVo cell growth by inhibiting EphB4 and the PI3K/AKT and MAPK/EKR1/2 signaling pathways. Food Chem Toxicol. 2019; 136:110960. DOI: 10.1016/j.fct.2019.110960. View

20.

Paraskevopoulou M, Hatzigeorgiou A . Analyzing MiRNA-LncRNA Interactions. Methods Mol Biol. 2016; 1402:271-286. DOI: 10.1007/978-1-4939-3378-5_21. View